TELA BIO INC. - COMMON STOCK
3.0100
22-November-24 15:44:58
15 minutes delayed
Stocks
+0.1200
+4.15%
Today's range
2.8200 - 3.1000
ISIN
N/A
Source
NASDAQ
-
TELA Bio Names Marissa Conrad as Vice President of Clinical and Regulatory Affairs
25 May 2021 06:00:01 By Nasdaq GlobeNewswire
-
TELA Bio to Participate in Upcoming Investor Conferences
21 May 2021 06:00:00 By Nasdaq GlobeNewswire
-
TELA Bio Initiates BRAVO II Study of OviTex® for the Robotic Repair of Ventral Hernias
19 May 2021 06:00:00 By Nasdaq GlobeNewswire
-
TELA Bio Announces First Quarter 2021 Financial Results
13 May 2021 15:02:00 By Nasdaq GlobeNewswire
-
TELA Bio to Announce First Quarter 2021 Financial Results
29 Apr 2021 15:00:00 By Nasdaq GlobeNewswire
-
TELA Bio Announces Fourth Quarter and Full Year 2020 Financial Results
24 Mar 2021 15:01:00 By Nasdaq GlobeNewswire
-
TELA Bio Announces 12-Month Analysis from BRAVO Study of OviTex® for Ventral Hernia Repair
18 Mar 2021 06:00:00 By Nasdaq GlobeNewswire
-
TELA Bio to Report Fourth Quarter and Full Year 2020 Financial Results on March 24, 2021
02 Mar 2021 06:00:01 By Nasdaq GlobeNewswire
-
04 Feb 2021 06:00:00 By Nasdaq GlobeNewswire
-
TELA Bio Reports Preliminary Results for Fourth Quarter and Full Year 2020
14 Jan 2021 06:00:00 By Nasdaq GlobeNewswire
-
TELA Bio to Participate in Upcoming Needham Virtual Growth Conference
06 Jan 2021 06:00:00 By Nasdaq GlobeNewswire
-
TELA Bio Appoints Renowned Surgeon as Vice President of Clinical Development
05 Jan 2021 06:00:01 By Nasdaq GlobeNewswire